Diffuse panbronchiolitis: report of a rare disease from India.
暂无分享,去创建一个
Initially described by a group of Japanese clinicians and pulmonary pathologists to distinguish it from other chronic obstructive lung diseases, diffuse panbronchiolitis (DPB) is an uncommon disorder which has been reported largely from the eastern world. It is imperative to recognise this condition because of its potentially treatable nature. Recently, long-term macrolide therapy has revolutionised its management. Herein, we describe a 65-year-old male who was being managed as a case of chronic bronchitis before this diagnosis was suspected and proved.
[1] S. Kudoh,et al. Contribution of HLA genes to genetic predisposition in diffuse panbronchiolitis. , 1998, American journal of respiratory and critical care medicine.
[2] E. Tanaka,et al. Diffuse panbronchiolitis in the United States. , 1997, American journal of respiratory and critical care medicine.
[3] S. Kudoh,et al. Analysis of HLA antigens in patients with diffuse panbronchiolitis. , 1990, The American review of respiratory disease.